Advanced Surgical Design & Manufacture Limited

Advanced Surgical designs and manufactures medical devices. Its principal product is the Active Knee, a prosthetic implant of which more than 3,000 have been implanted including 600+ in 2007. This product is supported by a range of Orthopaedic accessories and surgical tools and other Orthopaedic products.

Advanced Surgical provides a highly effective integrated service to surgeons building on its strengths in design and engineering. Core capabilities that underpin this service are integrated design and engineering, regulatory/compliance competency, manufacturing, distribution and customer service.

The company has built an extensive patent and product development portfolio through collaborative research relationships with universities, companies and surgeon inventors that extends beyond orthopaedics. These collaborations are yielding promising projects in several specialities with strong prospects for commercialisation over the next few years. 
 

News

Advanced Surgical Design and Manufacturer's (ASX: AMT) Pad Implant Featured on ABC Science Program "Catalyst"

🕔4/3/2008 12:35:31 PM 2920

Leading Australian developer and manufacturer of prosthetic implants and medical devices, Advanced Surgical Design and Manufacture Limited (ASX: AMT) announces that this Thursday's episode of Catalyst (ABC TV) will feature the Limb Saving clinical trial currently being undertaken by AllVascular Pty Ltd and utilising the PAD access device developed with Advanced Surgical and exclusively manufactured by Advanced Surgical.

Read Full Article
###

2,126 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 8) (Last 30 Days: 23) (Since Published: 2126) 

Company Data

    Headquarters
  • UNIT 2, 12 Fredrick Street
    St Leonards NSW 2065
    Australia
  • Telephone
  • 02 9439 4448 
  • Fax
  • 02 9439 4441 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.asdm.com.au

More News Results

  • 2024/07/23: Change in substantial holding*
  • 2024/07/22: Change in substantial holding*
  • 2024/07/19: First Supplementary Target's Statement*
  • 2024/07/19: Change in substantial holding*
  • 2024/07/17: Change in substantial holding*
  • 2024/07/11: Change in substantial holding*
  • 2024/07/10: Long Term Suspended Entities*
  • 2024/07/10: Extension of Offer Period*
  • 2024/07/10: Notice of Condition Fulfilled*
  • 2024/07/04: Lodgement of Target's Statement*
*refer to company website